| Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.800 | GeneticVariation | UNIPROT | |||||||||||
|
|
0.800 | CausalMutation | CGI | |||||||||||
|
|
0.700 | GenomicAlterations | CGI | |||||||||||
|
|
0.700 | CausalMutation | CGI | |||||||||||
|
|
0.600 | CausalMutation | CGI | |||||||||||
|
|
0.600 | CausalMutation | CGI | |||||||||||
|
|
0.600 | CausalMutation | CGI | |||||||||||
|
|
0.600 | CausalMutation | CGI | |||||||||||
|
|
0.600 | GenomicAlterations | CGI | |||||||||||
|
|
0.580 | GenomicAlterations | CGI | |||||||||||
|
|
0.580 | CausalMutation | CGI | |||||||||||
|
|
0.550 | CausalMutation | CGI | |||||||||||
|
|
0.500 | CausalMutation | CGI | |||||||||||
|
|
0.310 | GenomicAlterations | CGI | |||||||||||
|
|
0.300 | GenomicAlterations | CGI | |||||||||||
|
|
0.300 | CausalMutation | CGI | |||||||||||
|
|
0.300 | CausalMutation | CGI | |||||||||||
|
|
0.800 | Biomarker | CTD_human | DNA methylation markers and early recurrence in stage I lung cancer. | 18337602 | 2008 |
||||||||
|
|
0.800 | Biomarker | CTD_human | Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. | 20727180 | 2010 |
||||||||
|
|
0.800 | Biomarker | CTD_human | [Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82]. | 11798837 | 2000 |
||||||||
|
|
0.800 | Therapeutic | CTD_human | Genomic landscape of cutaneous T cell lymphoma. | 26192916 | 2015 |
||||||||
|
|
0.800 | Biomarker | CTD_human | Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. | 17325666 | 2007 |
||||||||
|
|
0.800 | Therapeutic | CTD_human | [Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82]. | 11798837 | 2000 |
||||||||
|
|
0.800 | Biomarker | CTD_human | Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. | 12115568 | 2002 |
||||||||
|
|
0.800 | Therapeutic | CTD_human | Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. | 17325666 | 2007 |